Your browser doesn't support javascript.
loading
EZH2 inhibition: a promising strategy to prevent cancer immune editing.
Kang, Ning; Eccleston, Mark; Clermont, Pier-Luc; Latarani, Maryam; Male, David Kingsley; Wang, Yuzhuo; Crea, Francesco.
Afiliação
  • Kang N; Department of Experimental Therapeutics, BC Cancer Research Centre, 675 West 10th Avenue, Vancouver, BC, V5Z 1L3, Canada.
  • Eccleston M; Belgian Volition SPRL, Parc Scientifique Créalys, Rue Phocas Lejeune 22, BE-5032 Isnes, Belgium.
  • Clermont PL; Faculty of Medicine, Université Laval, 1050, avenue de la Médecine, Québec, QC, G1V 0A6, Canada.
  • Latarani M; Cancer Research Group, School of Life Health & Chemical Sciences, The Open University, Walton Hall, Milton Keynes, MK7 6AA, UK.
  • Male DK; Cancer Research Group, School of Life Health & Chemical Sciences, The Open University, Walton Hall, Milton Keynes, MK7 6AA, UK.
  • Wang Y; Department of Experimental Therapeutics, BC Cancer Research Centre, 675 West 10th Avenue, Vancouver, BC, V5Z 1L3, Canada.
  • Crea F; Department of Urologic Sciences, The Vancouver Prostate Centre, The University of British Columbia, 2660 Oak St, Vancouver, BC, V6H 3Z6, Canada.
Epigenomics ; 12(16): 1457-1476, 2020 08.
Article em En | MEDLINE | ID: mdl-32938196

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Proteína Potenciadora do Homólogo 2 de Zeste / Neoplasias Limite: Animals / Humans Idioma: En Revista: Epigenomics Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Canadá

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Proteína Potenciadora do Homólogo 2 de Zeste / Neoplasias Limite: Animals / Humans Idioma: En Revista: Epigenomics Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Canadá